APPENDIX A TO PROXY STATEMENT
ADDITIONAL INFORMATION REGARDING PARTICIPANTS IN THE SOLICITATION
Under applicable SEC rules and regulations, any members of a group which solicits proxies are considered “participants” with respect to the Stockholder Group’s solicitation of proxies in connection with the Annual Meeting. The following sets forth certain information about the persons who are considered “participants.”
1. Stockholder Group and Nominees
The Participants are Dr. Morris C. Laster, Chen Laster, Gabriella Laster, Sara Laster, Mordechai Saar Hacham, and Joshua Levine.
Dr. Morris C. Laster’s business address is 11 Reuven Shari St, Jerusalem, Israel. Dr. Laster’s principal occupations are Medical Venture Partner at OurCrowd, Chairman of OncoHost and CEO of Clil Medical. The business address of Clil Medical is 11 Reuven Shari St, Jerusalem, Israel. The business address of OurCrowd is 28 Hebron Road, Jerusalem, Israel. The business address of OncoHost is HaMelacha St 6, Binyamina, Israel.
Chen Laster is a student and has a business address at Hapalmach 43; Jerusalem, Israel.
Sara Laster is a student and has a business address at 503 Shvo Street, Jerusalem, Israel.
Gabriella Laster’s business address is 16 Zeev Jabotinsky, Apartment 102, Ramat Gan, Israel. Gabriella Laster’s principal occupation is product marketing at Optimove, whose business address is 2 HaShlosha Street, Tel Aviv, Israel.
Mordechai Saar Hacham’s business address is 1 Agnon St., POB 6117, Ramat Hasharon, Israel. Mr. Hacham’s principal occupation is CFO of OncoHost, whose business address is 3 HaMelacha, Binyamina, Israel.
Joshua Levine’s business address is 25 Ahi Dakar Street, Raanana, Israel. Mr. Levine’s principal occupation is consultant to various entities, including the Israeli Institute for Biological Research and Seach Medical Group.
2. Information Regarding Ownership of the Company’s Securities by Participants
Dr. Morris C. Laster is the direct owner of 4,926,000 shares of the Company’s Common Stock, which were acquired through his role as co-founder, director and Chief Executive Officer of privately held predecessor companies that through acquisition, name changes, and financings became the Company. Chen Laster, Gabriella Laster and Sara Laster each directly own 360,000 shares of the Company’s Common Stock, which were received via transfer from Dr. Laster. The Stockholder Group beneficially own 6,006,000 shares of the Company’s Common Stock in aggregate. Except as described in this Appendix A or in this Proxy Statement, none of the persons listed above under “Stockholder Group and Nominees” owns any Company securities of record that they do not own beneficially.
3. Information Regarding Transactions in the Company’s Securities by Participants
None of the Participants have transacted in the Company’s securities in the past two (2) years.
4. Miscellaneous Information Concerning Participants
Except as described in this Appendix A or in this Proxy Statement, neither any participant nor any of their respective associates or affiliates (together, the “Participant Affiliates”) is either a party to any transaction or series of transactions since January 1, 2020 or has knowledge of any current proposed transaction or series of proposed transactions (i) to which the Company or any of its subsidiaries was or is to be a participant, (ii) in which the amount involved exceeds $120,000 and (iii) in which any participant or Participant Affiliate had, or will have, a direct or indirect material interest. Furthermore, except as described in this Appendix A or in this Proxy Statement, (a) no participant or Participant Affiliate, directly or indirectly,